Do I have it right that the basic thrust of the panel's report is that all medically necessary prescriptions that are evidence-based should be covered under the public system?
If someone wants to purchase a brand name over and above the generic, or some form of experimental medication, they are free do to so. The goal here is to make sure that every Canadian has access to medically necessary prescriptions under the public system. Do I have that right?